Agile Therapeutics (AGRX) PT Lowered to $4 at Oppenheimer, Keeps 'Outperform'
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell lowered the price target on Agile Therapeutics (NASDAQ: AGRX) to $4.00 (from $6.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
